Brazilian randomized study - impact of preoperative magnetic resonance in the evaluation for breast cancer conservative surgery
NCT ID NCT02798796
First seen Oct 23, 2026 · Last updated Oct 23, 2026
Summary
The aim of this study is to evaluate the ability of MRI to select patients for conservative treatment of breast cancer. Participants: female, over 18 years with breast cancer, stages I, II and III candidates for conservative surgery will be randomly randomized to do MRI or not according mammary density.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
446 people
The number who actually took part.
- Started
-
Nov 2014
- Finished
-
May 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Female, * Over 18 years with breast cancer * breast cancer stage 0 to III according to AJCC 7th Edition guideline Exclusion Criteria: * Contra-indication for breast MRI (ex. Metal implant) * Claustrophobia * Impossibility to stay in the prone position for more than an hour * History of allergic reaction to the paramagnetic contrast * History of chronic kidney disease on dialysis * Personal history of breast cancer treated surgically in the last 12 months. * Pregnancy or breastfeeding past 6 months
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Universidade de São Paulo
São Paulo, São Paulo, 01246903, Brazil
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Effect of cancer patient navigation services on Health-Illness transition readiness among women with newly diagnosed breast cancer: a Quasi-Experimental study
- A phase II, Open-Label, randomized study comparing antiangiogenic therapy combined with immunotherapy and capecitabine versus Investigator's choice in patients with circulating tumor DNA-Positive stage II-III Triple-Negative breast cancer who with residual disease after neoadjuvant therapy
- Toxicity and outcome of whole breast hypofractionated radiotherapy without boost: results of a homogeneous single institution experience
- Evaluation of the effect of amantadine in the prevention of Paclitaxel-Induced peripheral neuropathy in breast cancer patients
- Five fractions ultrahypofractionated whole breast radiotherapy and simultaneous integrated boost to the tumor bed, for breast cancer patients with unfavorable characteristics
- A post-market multi-center prospective study to assess the ability of the portable scalp cooling system (PSCS) to prevent hair loss in women receiving specific chemotherapy regimens for breast cancer stages I-III.